nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Paclitaxel—ovarian cancer	0.195	0.283	CbGbCtD
Eprosartan—ABCC2—Carboplatin—ovarian cancer	0.183	0.266	CbGbCtD
Eprosartan—ABCC2—Docetaxel—ovarian cancer	0.141	0.204	CbGbCtD
Eprosartan—ABCC2—Doxorubicin—ovarian cancer	0.105	0.152	CbGbCtD
Eprosartan—CYP2C9—Paclitaxel—ovarian cancer	0.0654	0.0949	CbGbCtD
Eprosartan—Palpitations—Paclitaxel—ovarian cancer	0.00041	0.00132	CcSEcCtD
Eprosartan—Vomiting—Melphalan—ovarian cancer	0.00041	0.00132	CcSEcCtD
Eprosartan—Hyponatraemia—Doxorubicin—ovarian cancer	0.000409	0.00132	CcSEcCtD
Eprosartan—Loss of consciousness—Paclitaxel—ovarian cancer	0.000408	0.00131	CcSEcCtD
Eprosartan—Osteoarthritis—Doxorubicin—ovarian cancer	0.000408	0.00131	CcSEcCtD
Eprosartan—Rash—Melphalan—ovarian cancer	0.000407	0.00131	CcSEcCtD
Eprosartan—Dermatitis—Melphalan—ovarian cancer	0.000406	0.00131	CcSEcCtD
Eprosartan—Chills—Docetaxel—ovarian cancer	0.000406	0.0013	CcSEcCtD
Eprosartan—Cough—Paclitaxel—ovarian cancer	0.000405	0.0013	CcSEcCtD
Eprosartan—Asthenia—Vinorelbine—ovarian cancer	0.000404	0.0013	CcSEcCtD
Eprosartan—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000403	0.00129	CcSEcCtD
Eprosartan—Migraine—Doxorubicin—ovarian cancer	0.000401	0.00129	CcSEcCtD
Eprosartan—Hypokalaemia—Epirubicin—ovarian cancer	0.000401	0.00129	CcSEcCtD
Eprosartan—Pruritus—Vinorelbine—ovarian cancer	0.000399	0.00128	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000397	0.00128	CcSEcCtD
Eprosartan—Arthralgia—Paclitaxel—ovarian cancer	0.000395	0.00127	CcSEcCtD
Eprosartan—Chest pain—Paclitaxel—ovarian cancer	0.000395	0.00127	CcSEcCtD
Eprosartan—Myalgia—Paclitaxel—ovarian cancer	0.000395	0.00127	CcSEcCtD
Eprosartan—Anxiety—Paclitaxel—ovarian cancer	0.000394	0.00127	CcSEcCtD
Eprosartan—Face oedema—Doxorubicin—ovarian cancer	0.000394	0.00127	CcSEcCtD
Eprosartan—Nausea—Topotecan—ovarian cancer	0.000391	0.00126	CcSEcCtD
Eprosartan—Discomfort—Paclitaxel—ovarian cancer	0.000391	0.00126	CcSEcCtD
Eprosartan—Gastritis—Epirubicin—ovarian cancer	0.00039	0.00125	CcSEcCtD
Eprosartan—Muscular weakness—Epirubicin—ovarian cancer	0.000389	0.00125	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000389	0.00125	CcSEcCtD
Eprosartan—Dry mouth—Paclitaxel—ovarian cancer	0.000387	0.00124	CcSEcCtD
Eprosartan—Diarrhoea—Vinorelbine—ovarian cancer	0.000385	0.00124	CcSEcCtD
Eprosartan—Ataxia—Doxorubicin—ovarian cancer	0.000383	0.00123	CcSEcCtD
Eprosartan—Nausea—Melphalan—ovarian cancer	0.000383	0.00123	CcSEcCtD
Eprosartan—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000382	0.00123	CcSEcCtD
Eprosartan—Asthma—Epirubicin—ovarian cancer	0.000381	0.00123	CcSEcCtD
Eprosartan—Back pain—Docetaxel—ovarian cancer	0.000381	0.00122	CcSEcCtD
Eprosartan—Muscle spasms—Docetaxel—ovarian cancer	0.000378	0.00122	CcSEcCtD
Eprosartan—Shock—Paclitaxel—ovarian cancer	0.000373	0.0012	CcSEcCtD
Eprosartan—Dizziness—Vinorelbine—ovarian cancer	0.000373	0.0012	CcSEcCtD
Eprosartan—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000372	0.0012	CcSEcCtD
Eprosartan—Hypokalaemia—Doxorubicin—ovarian cancer	0.000371	0.00119	CcSEcCtD
Eprosartan—Angina pectoris—Epirubicin—ovarian cancer	0.000371	0.00119	CcSEcCtD
Eprosartan—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000371	0.00119	CcSEcCtD
Eprosartan—Tachycardia—Paclitaxel—ovarian cancer	0.00037	0.00119	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000367	0.00118	CcSEcCtD
Eprosartan—Bronchitis—Epirubicin—ovarian cancer	0.000366	0.00118	CcSEcCtD
Eprosartan—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000366	0.00118	CcSEcCtD
Eprosartan—Anorexia—Paclitaxel—ovarian cancer	0.000361	0.00116	CcSEcCtD
Eprosartan—Gastritis—Doxorubicin—ovarian cancer	0.000361	0.00116	CcSEcCtD
Eprosartan—Muscular weakness—Doxorubicin—ovarian cancer	0.00036	0.00116	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00036	0.00116	CcSEcCtD
Eprosartan—Vomiting—Vinorelbine—ovarian cancer	0.000358	0.00115	CcSEcCtD
Eprosartan—Rash—Vinorelbine—ovarian cancer	0.000355	0.00114	CcSEcCtD
Eprosartan—Dermatitis—Vinorelbine—ovarian cancer	0.000355	0.00114	CcSEcCtD
Eprosartan—Hypotension—Paclitaxel—ovarian cancer	0.000354	0.00114	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000354	0.00114	CcSEcCtD
Eprosartan—Headache—Vinorelbine—ovarian cancer	0.000353	0.00113	CcSEcCtD
Eprosartan—Syncope—Docetaxel—ovarian cancer	0.000353	0.00113	CcSEcCtD
Eprosartan—Asthma—Doxorubicin—ovarian cancer	0.000352	0.00113	CcSEcCtD
Eprosartan—Pollakiuria—Epirubicin—ovarian cancer	0.000352	0.00113	CcSEcCtD
Eprosartan—Palpitations—Docetaxel—ovarian cancer	0.000348	0.00112	CcSEcCtD
Eprosartan—Loss of consciousness—Docetaxel—ovarian cancer	0.000346	0.00111	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000345	0.00111	CcSEcCtD
Eprosartan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000344	0.00111	CcSEcCtD
Eprosartan—Cough—Docetaxel—ovarian cancer	0.000343	0.0011	CcSEcCtD
Eprosartan—Angina pectoris—Doxorubicin—ovarian cancer	0.000343	0.0011	CcSEcCtD
Eprosartan—Insomnia—Paclitaxel—ovarian cancer	0.000343	0.0011	CcSEcCtD
Eprosartan—Paraesthesia—Paclitaxel—ovarian cancer	0.00034	0.00109	CcSEcCtD
Eprosartan—Bronchitis—Doxorubicin—ovarian cancer	0.000339	0.00109	CcSEcCtD
Eprosartan—Dyspnoea—Paclitaxel—ovarian cancer	0.000338	0.00109	CcSEcCtD
Eprosartan—Somnolence—Paclitaxel—ovarian cancer	0.000337	0.00108	CcSEcCtD
Eprosartan—Myalgia—Docetaxel—ovarian cancer	0.000335	0.00108	CcSEcCtD
Eprosartan—Chest pain—Docetaxel—ovarian cancer	0.000335	0.00108	CcSEcCtD
Eprosartan—Arthralgia—Docetaxel—ovarian cancer	0.000335	0.00108	CcSEcCtD
Eprosartan—Nausea—Vinorelbine—ovarian cancer	0.000335	0.00108	CcSEcCtD
Eprosartan—Renal failure—Epirubicin—ovarian cancer	0.000334	0.00107	CcSEcCtD
Eprosartan—Dyspepsia—Paclitaxel—ovarian cancer	0.000334	0.00107	CcSEcCtD
Eprosartan—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000333	0.00107	CcSEcCtD
Eprosartan—Conjunctivitis—Epirubicin—ovarian cancer	0.00033	0.00106	CcSEcCtD
Eprosartan—Urinary tract infection—Epirubicin—ovarian cancer	0.00033	0.00106	CcSEcCtD
Eprosartan—Decreased appetite—Paclitaxel—ovarian cancer	0.000329	0.00106	CcSEcCtD
Eprosartan—Dry mouth—Docetaxel—ovarian cancer	0.000328	0.00105	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000328	0.00105	CcSEcCtD
Eprosartan—Fatigue—Paclitaxel—ovarian cancer	0.000327	0.00105	CcSEcCtD
Eprosartan—Pollakiuria—Doxorubicin—ovarian cancer	0.000326	0.00105	CcSEcCtD
Eprosartan—Constipation—Paclitaxel—ovarian cancer	0.000324	0.00104	CcSEcCtD
Eprosartan—Pain—Paclitaxel—ovarian cancer	0.000324	0.00104	CcSEcCtD
Eprosartan—Haematuria—Epirubicin—ovarian cancer	0.000324	0.00104	CcSEcCtD
Eprosartan—Epistaxis—Epirubicin—ovarian cancer	0.00032	0.00103	CcSEcCtD
Eprosartan—Sinusitis—Epirubicin—ovarian cancer	0.000319	0.00102	CcSEcCtD
Eprosartan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000318	0.00102	CcSEcCtD
Eprosartan—Shock—Docetaxel—ovarian cancer	0.000316	0.00102	CcSEcCtD
Eprosartan—Thrombocytopenia—Docetaxel—ovarian cancer	0.000314	0.00101	CcSEcCtD
Eprosartan—Tachycardia—Docetaxel—ovarian cancer	0.000313	0.00101	CcSEcCtD
Eprosartan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000312	0.001	CcSEcCtD
Eprosartan—Bradycardia—Epirubicin—ovarian cancer	0.00031	0.000998	CcSEcCtD
Eprosartan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00031	0.000996	CcSEcCtD
Eprosartan—Renal failure—Doxorubicin—ovarian cancer	0.000309	0.000994	CcSEcCtD
Eprosartan—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000308	0.000991	CcSEcCtD
Eprosartan—Anorexia—Docetaxel—ovarian cancer	0.000306	0.000985	CcSEcCtD
Eprosartan—Rhinitis—Epirubicin—ovarian cancer	0.000306	0.000983	CcSEcCtD
Eprosartan—Conjunctivitis—Doxorubicin—ovarian cancer	0.000305	0.000982	CcSEcCtD
Eprosartan—Urinary tract infection—Doxorubicin—ovarian cancer	0.000305	0.000982	CcSEcCtD
Eprosartan—Pharyngitis—Epirubicin—ovarian cancer	0.000303	0.000973	CcSEcCtD
Eprosartan—Urticaria—Paclitaxel—ovarian cancer	0.000301	0.000968	CcSEcCtD
Eprosartan—Oedema peripheral—Epirubicin—ovarian cancer	0.0003	0.000966	CcSEcCtD
Eprosartan—Hypotension—Docetaxel—ovarian cancer	0.0003	0.000965	CcSEcCtD
Eprosartan—Haematuria—Doxorubicin—ovarian cancer	0.0003	0.000964	CcSEcCtD
Eprosartan—Body temperature increased—Paclitaxel—ovarian cancer	0.0003	0.000963	CcSEcCtD
Eprosartan—Abdominal pain—Paclitaxel—ovarian cancer	0.0003	0.000963	CcSEcCtD
Eprosartan—Epistaxis—Doxorubicin—ovarian cancer	0.000296	0.000953	CcSEcCtD
Eprosartan—Sinusitis—Doxorubicin—ovarian cancer	0.000295	0.000948	CcSEcCtD
Eprosartan—Visual impairment—Epirubicin—ovarian cancer	0.000294	0.000945	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000293	0.000941	CcSEcCtD
Eprosartan—Insomnia—Docetaxel—ovarian cancer	0.00029	0.000934	CcSEcCtD
Eprosartan—Paraesthesia—Docetaxel—ovarian cancer	0.000288	0.000927	CcSEcCtD
Eprosartan—Bradycardia—Doxorubicin—ovarian cancer	0.000287	0.000924	CcSEcCtD
Eprosartan—Dyspnoea—Docetaxel—ovarian cancer	0.000286	0.000921	CcSEcCtD
Eprosartan—Somnolence—Docetaxel—ovarian cancer	0.000286	0.000918	CcSEcCtD
Eprosartan—Tinnitus—Epirubicin—ovarian cancer	0.000284	0.000914	CcSEcCtD
Eprosartan—Rhinitis—Doxorubicin—ovarian cancer	0.000283	0.00091	CcSEcCtD
Eprosartan—Dyspepsia—Docetaxel—ovarian cancer	0.000283	0.000909	CcSEcCtD
Eprosartan—Pharyngitis—Doxorubicin—ovarian cancer	0.00028	0.000901	CcSEcCtD
Eprosartan—Decreased appetite—Docetaxel—ovarian cancer	0.000279	0.000898	CcSEcCtD
Eprosartan—Hypersensitivity—Paclitaxel—ovarian cancer	0.000279	0.000898	CcSEcCtD
Eprosartan—Oedema peripheral—Doxorubicin—ovarian cancer	0.000278	0.000894	CcSEcCtD
Eprosartan—Fatigue—Docetaxel—ovarian cancer	0.000277	0.000891	CcSEcCtD
Eprosartan—Constipation—Docetaxel—ovarian cancer	0.000275	0.000883	CcSEcCtD
Eprosartan—Pain—Docetaxel—ovarian cancer	0.000275	0.000883	CcSEcCtD
Eprosartan—Chills—Epirubicin—ovarian cancer	0.000274	0.00088	CcSEcCtD
Eprosartan—Visual impairment—Doxorubicin—ovarian cancer	0.000272	0.000874	CcSEcCtD
Eprosartan—Asthenia—Paclitaxel—ovarian cancer	0.000272	0.000874	CcSEcCtD
Eprosartan—Pruritus—Paclitaxel—ovarian cancer	0.000268	0.000862	CcSEcCtD
Eprosartan—Feeling abnormal—Docetaxel—ovarian cancer	0.000265	0.000851	CcSEcCtD
Eprosartan—Tinnitus—Doxorubicin—ovarian cancer	0.000263	0.000846	CcSEcCtD
Eprosartan—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000263	0.000845	CcSEcCtD
Eprosartan—Flatulence—Epirubicin—ovarian cancer	0.000262	0.000841	CcSEcCtD
Eprosartan—Tension—Epirubicin—ovarian cancer	0.00026	0.000838	CcSEcCtD
Eprosartan—Diarrhoea—Paclitaxel—ovarian cancer	0.000259	0.000834	CcSEcCtD
Eprosartan—Nervousness—Epirubicin—ovarian cancer	0.000258	0.000829	CcSEcCtD
Eprosartan—Back pain—Epirubicin—ovarian cancer	0.000257	0.000826	CcSEcCtD
Eprosartan—Muscle spasms—Epirubicin—ovarian cancer	0.000255	0.000821	CcSEcCtD
Eprosartan—Abdominal pain—Docetaxel—ovarian cancer	0.000254	0.000817	CcSEcCtD
Eprosartan—Body temperature increased—Docetaxel—ovarian cancer	0.000254	0.000817	CcSEcCtD
Eprosartan—Chills—Doxorubicin—ovarian cancer	0.000253	0.000814	CcSEcCtD
Eprosartan—Dizziness—Paclitaxel—ovarian cancer	0.000251	0.000806	CcSEcCtD
Eprosartan—Ill-defined disorder—Epirubicin—ovarian cancer	0.000246	0.000792	CcSEcCtD
Eprosartan—Flatulence—Doxorubicin—ovarian cancer	0.000242	0.000778	CcSEcCtD
Eprosartan—Tension—Doxorubicin—ovarian cancer	0.000241	0.000775	CcSEcCtD
Eprosartan—Vomiting—Paclitaxel—ovarian cancer	0.000241	0.000775	CcSEcCtD
Eprosartan—Malaise—Epirubicin—ovarian cancer	0.000239	0.00077	CcSEcCtD
Eprosartan—Rash—Paclitaxel—ovarian cancer	0.000239	0.000768	CcSEcCtD
Eprosartan—Dermatitis—Paclitaxel—ovarian cancer	0.000239	0.000768	CcSEcCtD
Eprosartan—Nervousness—Doxorubicin—ovarian cancer	0.000239	0.000767	CcSEcCtD
Eprosartan—Vertigo—Epirubicin—ovarian cancer	0.000238	0.000767	CcSEcCtD
Eprosartan—Syncope—Epirubicin—ovarian cancer	0.000238	0.000766	CcSEcCtD
Eprosartan—Back pain—Doxorubicin—ovarian cancer	0.000238	0.000764	CcSEcCtD
Eprosartan—Headache—Paclitaxel—ovarian cancer	0.000237	0.000763	CcSEcCtD
Eprosartan—Hypersensitivity—Docetaxel—ovarian cancer	0.000237	0.000761	CcSEcCtD
Eprosartan—Muscle spasms—Doxorubicin—ovarian cancer	0.000236	0.000759	CcSEcCtD
Eprosartan—Palpitations—Epirubicin—ovarian cancer	0.000235	0.000754	CcSEcCtD
Eprosartan—Loss of consciousness—Epirubicin—ovarian cancer	0.000233	0.00075	CcSEcCtD
Eprosartan—Cough—Epirubicin—ovarian cancer	0.000232	0.000745	CcSEcCtD
Eprosartan—Asthenia—Docetaxel—ovarian cancer	0.00023	0.000741	CcSEcCtD
Eprosartan—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000228	0.000733	CcSEcCtD
Eprosartan—Pruritus—Docetaxel—ovarian cancer	0.000227	0.000731	CcSEcCtD
Eprosartan—Myalgia—Epirubicin—ovarian cancer	0.000226	0.000727	CcSEcCtD
Eprosartan—Chest pain—Epirubicin—ovarian cancer	0.000226	0.000727	CcSEcCtD
Eprosartan—Arthralgia—Epirubicin—ovarian cancer	0.000226	0.000727	CcSEcCtD
Eprosartan—Anxiety—Epirubicin—ovarian cancer	0.000225	0.000724	CcSEcCtD
Eprosartan—Nausea—Paclitaxel—ovarian cancer	0.000225	0.000724	CcSEcCtD
Eprosartan—Discomfort—Epirubicin—ovarian cancer	0.000223	0.000718	CcSEcCtD
Eprosartan—Malaise—Doxorubicin—ovarian cancer	0.000221	0.000712	CcSEcCtD
Eprosartan—Dry mouth—Epirubicin—ovarian cancer	0.000221	0.000711	CcSEcCtD
Eprosartan—Vertigo—Doxorubicin—ovarian cancer	0.000221	0.00071	CcSEcCtD
Eprosartan—Syncope—Doxorubicin—ovarian cancer	0.00022	0.000708	CcSEcCtD
Eprosartan—Diarrhoea—Docetaxel—ovarian cancer	0.00022	0.000707	CcSEcCtD
Eprosartan—Palpitations—Doxorubicin—ovarian cancer	0.000217	0.000698	CcSEcCtD
Eprosartan—Loss of consciousness—Doxorubicin—ovarian cancer	0.000216	0.000694	CcSEcCtD
Eprosartan—Cough—Doxorubicin—ovarian cancer	0.000214	0.000689	CcSEcCtD
Eprosartan—Shock—Epirubicin—ovarian cancer	0.000213	0.000685	CcSEcCtD
Eprosartan—Dizziness—Docetaxel—ovarian cancer	0.000212	0.000683	CcSEcCtD
Eprosartan—Thrombocytopenia—Epirubicin—ovarian cancer	0.000212	0.000682	CcSEcCtD
Eprosartan—Tachycardia—Epirubicin—ovarian cancer	0.000211	0.00068	CcSEcCtD
Eprosartan—Hyperhidrosis—Epirubicin—ovarian cancer	0.000209	0.000674	CcSEcCtD
Eprosartan—Chest pain—Doxorubicin—ovarian cancer	0.000209	0.000672	CcSEcCtD
Eprosartan—Myalgia—Doxorubicin—ovarian cancer	0.000209	0.000672	CcSEcCtD
Eprosartan—Arthralgia—Doxorubicin—ovarian cancer	0.000209	0.000672	CcSEcCtD
Eprosartan—Anxiety—Doxorubicin—ovarian cancer	0.000208	0.00067	CcSEcCtD
Eprosartan—Discomfort—Doxorubicin—ovarian cancer	0.000207	0.000664	CcSEcCtD
Eprosartan—Anorexia—Epirubicin—ovarian cancer	0.000206	0.000664	CcSEcCtD
Eprosartan—Dry mouth—Doxorubicin—ovarian cancer	0.000204	0.000658	CcSEcCtD
Eprosartan—Vomiting—Docetaxel—ovarian cancer	0.000204	0.000657	CcSEcCtD
Eprosartan—Rash—Docetaxel—ovarian cancer	0.000203	0.000651	CcSEcCtD
Eprosartan—Hypotension—Epirubicin—ovarian cancer	0.000202	0.000651	CcSEcCtD
Eprosartan—Dermatitis—Docetaxel—ovarian cancer	0.000202	0.000651	CcSEcCtD
Eprosartan—Headache—Docetaxel—ovarian cancer	0.000201	0.000647	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000197	0.000635	CcSEcCtD
Eprosartan—Shock—Doxorubicin—ovarian cancer	0.000197	0.000634	CcSEcCtD
Eprosartan—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000196	0.000631	CcSEcCtD
Eprosartan—Insomnia—Epirubicin—ovarian cancer	0.000196	0.00063	CcSEcCtD
Eprosartan—Tachycardia—Doxorubicin—ovarian cancer	0.000196	0.000629	CcSEcCtD
Eprosartan—Paraesthesia—Epirubicin—ovarian cancer	0.000195	0.000626	CcSEcCtD
Eprosartan—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000194	0.000623	CcSEcCtD
Eprosartan—Dyspnoea—Epirubicin—ovarian cancer	0.000193	0.000621	CcSEcCtD
Eprosartan—Somnolence—Epirubicin—ovarian cancer	0.000193	0.000619	CcSEcCtD
Eprosartan—Anorexia—Doxorubicin—ovarian cancer	0.000191	0.000614	CcSEcCtD
Eprosartan—Nausea—Docetaxel—ovarian cancer	0.000191	0.000614	CcSEcCtD
Eprosartan—Dyspepsia—Epirubicin—ovarian cancer	0.000191	0.000613	CcSEcCtD
Eprosartan—Decreased appetite—Epirubicin—ovarian cancer	0.000188	0.000606	CcSEcCtD
Eprosartan—Hypotension—Doxorubicin—ovarian cancer	0.000187	0.000602	CcSEcCtD
Eprosartan—Fatigue—Epirubicin—ovarian cancer	0.000187	0.000601	CcSEcCtD
Eprosartan—Pain—Epirubicin—ovarian cancer	0.000185	0.000596	CcSEcCtD
Eprosartan—Constipation—Epirubicin—ovarian cancer	0.000185	0.000596	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000183	0.000587	CcSEcCtD
Eprosartan—Insomnia—Doxorubicin—ovarian cancer	0.000181	0.000583	CcSEcCtD
Eprosartan—Paraesthesia—Doxorubicin—ovarian cancer	0.00018	0.000579	CcSEcCtD
Eprosartan—Dyspnoea—Doxorubicin—ovarian cancer	0.000179	0.000575	CcSEcCtD
Eprosartan—Feeling abnormal—Epirubicin—ovarian cancer	0.000179	0.000574	CcSEcCtD
Eprosartan—Somnolence—Doxorubicin—ovarian cancer	0.000178	0.000573	CcSEcCtD
Eprosartan—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000177	0.00057	CcSEcCtD
Eprosartan—Dyspepsia—Doxorubicin—ovarian cancer	0.000176	0.000567	CcSEcCtD
Eprosartan—Decreased appetite—Doxorubicin—ovarian cancer	0.000174	0.00056	CcSEcCtD
Eprosartan—Fatigue—Doxorubicin—ovarian cancer	0.000173	0.000556	CcSEcCtD
Eprosartan—Urticaria—Epirubicin—ovarian cancer	0.000172	0.000553	CcSEcCtD
Eprosartan—Constipation—Doxorubicin—ovarian cancer	0.000171	0.000551	CcSEcCtD
Eprosartan—Pain—Doxorubicin—ovarian cancer	0.000171	0.000551	CcSEcCtD
Eprosartan—Abdominal pain—Epirubicin—ovarian cancer	0.000171	0.000551	CcSEcCtD
Eprosartan—Body temperature increased—Epirubicin—ovarian cancer	0.000171	0.000551	CcSEcCtD
Eprosartan—Feeling abnormal—Doxorubicin—ovarian cancer	0.000165	0.000531	CcSEcCtD
Eprosartan—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000164	0.000527	CcSEcCtD
Eprosartan—Hypersensitivity—Epirubicin—ovarian cancer	0.00016	0.000513	CcSEcCtD
Eprosartan—Urticaria—Doxorubicin—ovarian cancer	0.000159	0.000512	CcSEcCtD
Eprosartan—Body temperature increased—Doxorubicin—ovarian cancer	0.000158	0.00051	CcSEcCtD
Eprosartan—Abdominal pain—Doxorubicin—ovarian cancer	0.000158	0.00051	CcSEcCtD
Eprosartan—Asthenia—Epirubicin—ovarian cancer	0.000155	0.0005	CcSEcCtD
Eprosartan—Pruritus—Epirubicin—ovarian cancer	0.000153	0.000493	CcSEcCtD
Eprosartan—Diarrhoea—Epirubicin—ovarian cancer	0.000148	0.000477	CcSEcCtD
Eprosartan—Hypersensitivity—Doxorubicin—ovarian cancer	0.000148	0.000475	CcSEcCtD
Eprosartan—Asthenia—Doxorubicin—ovarian cancer	0.000144	0.000463	CcSEcCtD
Eprosartan—Dizziness—Epirubicin—ovarian cancer	0.000143	0.000461	CcSEcCtD
Eprosartan—Pruritus—Doxorubicin—ovarian cancer	0.000142	0.000456	CcSEcCtD
Eprosartan—Vomiting—Epirubicin—ovarian cancer	0.000138	0.000443	CcSEcCtD
Eprosartan—Diarrhoea—Doxorubicin—ovarian cancer	0.000137	0.000441	CcSEcCtD
Eprosartan—Rash—Epirubicin—ovarian cancer	0.000137	0.000439	CcSEcCtD
Eprosartan—Dermatitis—Epirubicin—ovarian cancer	0.000136	0.000439	CcSEcCtD
Eprosartan—Headache—Epirubicin—ovarian cancer	0.000136	0.000436	CcSEcCtD
Eprosartan—Dizziness—Doxorubicin—ovarian cancer	0.000133	0.000426	CcSEcCtD
Eprosartan—Nausea—Epirubicin—ovarian cancer	0.000129	0.000414	CcSEcCtD
Eprosartan—Vomiting—Doxorubicin—ovarian cancer	0.000127	0.00041	CcSEcCtD
Eprosartan—Rash—Doxorubicin—ovarian cancer	0.000126	0.000406	CcSEcCtD
Eprosartan—Dermatitis—Doxorubicin—ovarian cancer	0.000126	0.000406	CcSEcCtD
Eprosartan—Headache—Doxorubicin—ovarian cancer	0.000126	0.000404	CcSEcCtD
Eprosartan—Nausea—Doxorubicin—ovarian cancer	0.000119	0.000383	CcSEcCtD
